PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23022345-4	2012	Here we examine the capacity of fibrous poly epsilon-caprolactone (PCL) scaffolds, biofunctionalised with immobilised glial cell-derived neurotrophic factor (GDNF), to influence primary cortical neural stem cells/progenitors in vitro and enhance integration of these cells following transplantation into the brain parenchyma.	polycaprolactone	67-70	glial cell derived neurotrophic factor	Homo sapiens	118-156	
23022345-6	2012	In vitro, we demonstrate that PCL with immobilised GDNF (iGDNF) significantly enhances cell viability and neural stem cell/progenitor proliferation compared to conventional 2-dimensional cultureware.	polycaprolactone	30-33	glial cell derived neurotrophic factor	Homo sapiens	51-55	
25786730-0	2014	Controlled release of glial cell line-derived neurotrophic factor from poly(epsilon-caprolactone) microspheres.	polycaprolactone	71-97	glial cell derived neurotrophic factor	Homo sapiens	22-65	
25786730-3	2014	As a proof of concept, we encapsulated GDNF into poly(epsilon-caprolactone) (PCL) microspheres to enable controlled drug release for 25 days.	polycaprolactone	49-75	glial cell derived neurotrophic factor	Homo sapiens	39-43	
25786730-3	2014	As a proof of concept, we encapsulated GDNF into poly(epsilon-caprolactone) (PCL) microspheres to enable controlled drug release for 25 days.	polycaprolactone	77-80	glial cell derived neurotrophic factor	Homo sapiens	39-43	
32262904-4	2015	This work focuses on designing a novel class of encapsulated poly(epsilon-caprolactone) (PCL) nanofiber scaffolds with different topographies (random and aligned) that generate controlled release of GDNF to potentially serve as a suitable substitute for the dura mater during neurosurgical procedures.	polycaprolactone	61-87	glial cell derived neurotrophic factor	Homo sapiens	199-203	
32262904-4	2015	This work focuses on designing a novel class of encapsulated poly(epsilon-caprolactone) (PCL) nanofiber scaffolds with different topographies (random and aligned) that generate controlled release of GDNF to potentially serve as a suitable substitute for the dura mater during neurosurgical procedures.	polycaprolactone	89-92	glial cell derived neurotrophic factor	Homo sapiens	199-203	
24700461-6	2014	Enzyme-linked immunosorbent assays (ELISA) revealed that GDNF, covalently tethered onto polycaprolactone (PCL) electrospun nanofibrous scaffolds, remained present on the scaffold surface for 120 days, with no evidence of protein leaching or degradation.	polycaprolactone	88-104	glial cell derived neurotrophic factor	Homo sapiens	57-61	
24700461-6	2014	Enzyme-linked immunosorbent assays (ELISA) revealed that GDNF, covalently tethered onto polycaprolactone (PCL) electrospun nanofibrous scaffolds, remained present on the scaffold surface for 120 days, with no evidence of protein leaching or degradation.	polycaprolactone	106-109	glial cell derived neurotrophic factor	Homo sapiens	57-61